Influence of B Cell Depletion By Monoclonal Anti CD20 Antibodies in Systemic Sclerosis: Results of a Randomized Placebo Controlled Trial

被引：0
作者：
Ben Said-Bouyeri, Samira [1 ]
Meijs, Jessica [1 ]
Marsan, Nina Ajmone [2 ]
Schouffoer, Anne A. [1 ]
Ninaber, Maarten K. [3 ]
Scherer, Hans Ulrich [4 ]
Bonte-Mineur, Femke [5 ]
Huizinga, T. W. J. [1 ]
de Vries-Bouwstra, Jeska K. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Rheumatol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Cardiol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Pulmonol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[5] Maasstad Hosp, Rotterdam, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
836
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacodynamics of B-Cell Depletion and Pharmacokinetics of the Novel Anti-CD20 Monoclonal Antibody Ublituximab in Patients With Relapsing Multiple Sclerosis
    Fox, E.
    Steinman, L.
    Hartung, H.
    Alvarez, E.
    Qian, P.
    Wray, S.
    Robertson, D.
    Huang, D.
    Selmaj, K.
    Wynn, D.
    Weiss, M. S.
    Bosco, J. A.
    Power, S. A.
    Mok, K. A.
    Lee, L.
    Cree, B. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 68 - 68
  • [42] CLINICAL EFFICACY OF ANTI-THYMOCYE GLOBULIN IN SYSTEMIC-SCLEROSIS - RESULTS OF A PLACEBO-CONTROLLED TRIAL
    SINCLAIR, HD
    WILLIAMS, JD
    RAHMAN, MA
    DENTON, C
    BLACK, CM
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S217 - S217
  • [43] Ibrutinib Exposure and B-Cell Depletion Induced By Anti-CD20 Monoclonal Antibodies Rituximab and Obinutuzumab: Is There a Rationale for Combination Studies?
    Ysebaert, Loic
    Klein, Christian
    Quillet-Mary, Anne
    [J]. BLOOD, 2014, 124 (21)
  • [44] B cell depletion by anti-CD20 antibodies entrains trabecular bone loss in mice
    Kolomansky, A.
    Deshet-Unger, N.
    Ostrovsky, A.
    Hiram-Bab, S.
    Ben-Califa, N.
    Liron, T.
    Oster, H. S.
    Mittelman, M.
    Gabet, Y.
    Neumann, D.
    [J]. FEBS JOURNAL, 2017, 284 : 141 - 141
  • [45] Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)
    Bruzzese, V.
    Pepe, J.
    [J]. REUMATISMO, 2009, 61 (04) : 306 - 308
  • [46] Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
    Albert, D.
    Dunham, J.
    Khan, S.
    Stansberry, J.
    Kolasinski, S.
    Tsai, D.
    Pullman-Mooar, S.
    Barnack, F.
    Striebich, C.
    Looney, R. J.
    Prak, E. T. Luning
    Kimberly, R.
    Zhang, Y.
    Eisenberg, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1724 - 1731
  • [47] Analysis of the CD19 and CD20 antibodies in the B cell section of the workshop.
    Sato, S
    Ono, N
    Tedder, TF
    [J]. TISSUE ANTIGENS, 1996, 48 (4-II): : BC301 - BC301
  • [48] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Robak, Tadeusz
    Robak, Ewa
    [J]. BIODRUGS, 2011, 25 (01) : 13 - 25
  • [49] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Tadeusz Robak
    Ewa Robak
    [J]. BioDrugs, 2011, 25 : 13 - 25
  • [50] Anti-CD20 monoclonal antibodies: Beyond B-cells
    Avivi, Irit
    Stroopinsky, Dina
    Katz, Tamar
    [J]. BLOOD REVIEWS, 2013, 27 (05) : 217 - 223
12345